Earnings NurExone’s 30-for-1 Share Consolidation: A High-Stakes Bet on US Market Access
The arithmetic is stark: thirty shares become one. That is the proposal NurExone Biologic will put before shareholders at its annual and special meeting on September 15, 2026, when investors...